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Background:  paracrine activity of pericoronary adipose tissue (PCAT) may adversely affect coronary lesions formation and plaque 
stability. Maximal standardized uptake value (SUV) of 18-fluorodeoxyglucose (FDG) measurement by positron emission tomography has 
been proved to be an efficient tool to evaluate proinflammatory activity of different tissues. In patients with stable coronary artery disease it 
correlated with % of coronary stenosis. We sought to investigate, whether PCAT influenced plaque composition in Non-ST elevation Acute 
Coronary Syndromes (NSTE-ACS) patients.
methods:  30 patients (98 coronary arteries: LM, RCA, LCX, LAD) have been investigated in non-diabetic subjects with moderate/low risk 
NSTE-ACS (GRACE <140). SUV was measured in PCAT surrounding arteries on the sections corresponding to coronary plaques detected 
by gray scale intravascular ultrasound and virtual histology (VH-IVUS) during routine coronarography. Additionally SUV was measured in 
subcutaneous fat (SC), visceral thoracic fat (VS), epicardial fat over right ventricle (EPI). Qualitative (calcified, fibrous, fibro-fatty, or necrotic 
core) and quantitative analyses of plaques were performed, and further correlated with PCAT SUV. In all patients Homeostasis Model of 
Assessment - Insulin Resistance (HOMA-IR) was calculated using the formula: fasting Glucose (mmol/L) x fasting Insulin (µU/L)/22.5.
results:  PVAT SUV in NSTE-ACS patients was significantly greater than in other fat locations (LM SUV: 1.60; RCA SUV: 1.47; LCX SUV: 
1.89 LAD SUV: 2.30 vs SC SUV: 0.59; VS SUV: 0.78; EPI SUV: 0.99, p<0.001; ANOVA). PCAT SUV positively correlated with necrotic 
core plaque rate (r=0.61, p<0.05), and negatively correlated with fibrous plaque rate (r=-0.52, p2.5 (r=0.70, p<0.05 r=-0.59, p<0.05, 
respectively). There was also positive correlation between PCAT SUV and % plaque volume (r=0.45, p<0.05).
conclusion:  Inflammatory activity of PCAT is greater than in subcutaneous, visceral thoracic, or epicardial tissue in NSTE-ACS patients; 
PCAT SUV correlates with necrotic core component of coronary plaque and plaque volume in patents with NSTE-ACS, especially with 
elevated insulin resistance index.
